GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Avalon Globocare Corp (FRA:2XJ0) » Definitions » Cyclically Adjusted PS Ratio

Avalon Globocare (FRA:2XJ0) Cyclically Adjusted PS Ratio : (As of Sep. 21, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Avalon Globocare Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Avalon Globocare Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Avalon Globocare's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalon Globocare Cyclically Adjusted PS Ratio Chart

Avalon Globocare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.40

Avalon Globocare Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 2.40 1.58 2.34

Competitive Comparison of Avalon Globocare's Cyclically Adjusted PS Ratio

For the Real Estate Services subindustry, Avalon Globocare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avalon Globocare's Cyclically Adjusted PS Ratio Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Avalon Globocare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Avalon Globocare's Cyclically Adjusted PS Ratio falls into.



Avalon Globocare Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Avalon Globocare's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Avalon Globocare's adjusted Revenue per Share data for the three months ended in Jun. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.028/132.5538*132.5538
=0.028

Current CPI (Jun. 2024) = 132.5538.

Avalon Globocare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.058 101.861 0.075
201612 0.050 101.863 0.065
201703 0.010 102.862 0.013
201706 0.052 103.349 0.067
201709 0.041 104.136 0.052
201712 0.040 104.011 0.051
201803 0.036 105.290 0.045
201806 0.059 106.317 0.074
201809 0.049 106.507 0.061
201812 0.041 105.998 0.051
201903 0.034 107.251 0.042
201906 0.047 108.070 0.058
201909 0.046 108.329 0.056
201912 0.057 108.420 0.070
202003 0.035 108.902 0.043
202006 0.034 108.767 0.041
202009 0.034 109.815 0.041
202012 0.046 109.897 0.055
202103 0.029 111.754 0.034
202106 0.027 114.631 0.031
202109 0.049 115.734 0.056
202112 0.034 117.630 0.038
202203 0.031 121.301 0.034
202206 0.031 125.017 0.033
202209 0.033 125.227 0.035
202212 0.028 125.222 0.030
202303 0.028 127.348 0.029
202306 0.028 128.729 0.029
202309 0.029 129.860 0.030
202312 0.027 129.419 0.028
202403 0.027 131.776 0.027
202406 0.028 132.554 0.028

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Avalon Globocare  (FRA:2XJ0) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Avalon Globocare Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Avalon Globocare's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Avalon Globocare Business Description

Traded in Other Exchanges
Address
4400 Route 9 South, Suite 3100, Freehold, NJ, USA, 07728
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Avalon Globocare Headlines

No Headlines